Answers are grounded in this paper and cite their sources.
High Resolution Image Download MS PowerPoint Slide In this study, a series of azo-linked imidazo[1,2- a ]pyridine derivatives ( 4a – f ) was synthesized and fully characterized using FTIR, NMR ( 1 H and 13 C), and mass spectrometry. Structural and electronic properties were investigated through Density Functional Theory (DFT) at the B3LYP/6-311++G(d,p) level, revealing key insights into charge distribution, molecular orbitals, and reactivity indices. The antibacterial and antibiofilm activities were assessed in vitro against Gram-positive and Gram-negative strains, including multidrug-resistant isolates. 4e exhibited the most potent antibacterial activity, with minimum inhibitory concentrations (MICs) of 0.5–1.0 mg/mL, and retained activity against resistant strains, showing MICs of 0.5–0.7 mg/mL against Escherichia coli CTXM and Klebsiella pneumoniae NDM . 4b and 4c notably inhibited biofilm formation at concentrations as low as 0.4 mg/mL against E. coli . Molecular docking studies indicated strong binding affinities for the active compounds, with 4b achieving the most favorable docking score (−10.4 kcal/mol) against the bacterial target GyrB. These binding interactions were further corroborated by molecular dynamics simulations, which demonstrated stable protein–ligand complexes over a 100 ns trajectory with minimal structural deviations. Additionally, ADME-T and drug-likeness evaluations predicted favorable pharmacokinetic profiles for the majority of the compounds, highlighting their viability for further development. Overall, this study establishes azo-based imidazo[1,2- a ]pyridine derivatives as promising scaffolds for future antibacterial drug discovery.
No takes yet. Share an insight, caveat, or question.
Azzouzi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: